|
In situ targeted drug delivery to sites of intravascular heterotypic aggregates in sickle cell disease (SCD) by red blood cells encapsulated with drug candidates.
In situ targeted drug delivery to sites of intravascular heterotypic aggregates in sickle cell disease (SCD) by red blood cells encapsulated with drug candidates
Background
Recent advances highlight potential use of red blood cells (RBCs) as efficient drug delivery systems (DDS) for sickle cell disorders (SCD), either by incorporating the...
Published: 3/20/2026
|
Updated: 7/17/2023
|
Inventor(s): Leslie Silberstein, Shin-Young Park, Jina Ryu, Min Liu
Keywords(s): Immunology
Category(s): Technology Classifications > Disease Area, Technology Classifications > Disease Area > Rare Diseases, Technology Classifications > Disease Area > Hematology, Technology Classifications > Invention Type, Technology Classifications > Invention Type > Therapeutics, Technology Classifications > Invention Type > Therapeutics > Drug Delivery
|
